George A. Bray, M.D.

Boyd Professor, Chief, Division of Clinical Obesity and Metabolism Professor,
Pennington Biomedical Research Center

Education
M.D., Harvard Medical School, Boston, MA, 1953-1957

Research Interests
Dr. Bray is an internationally recognized researcher whose major research interests have been in obesity and diabetes at both the experimental and clinical level. Dr. Bray has received many awards during his medical career. They have included: the Johns Hopkins Society of Scholars; Honorary Fellow, American Dietetic Association; Joseph Goldberger Award from the American Medical Association; the McCollum Award from the American Society of Clinical Nutrition; the Osborne-Mendel Award from the American Society of Nutrition; The TOPS Award from NAASO; the Weight Watchers Award; the Bristol-Myers Squibb Mead Johnson Award in Nutrition; and the Stunkard Lifetime Achievement Award.

During the past 40 years, Dr. Bray has authored or coauthored more than 1,700 publications, ranging from peer-reviewed articles to reviews, books, book chapters and abstracts. Dr. Bray was an early investigator into the puzzling nature of hyperphagia in Prader-Willi syndrome.

Selected Publications
Neuropeptide Y administration into the amygdala alters high fat food intake. Primeaux SD, York DA, Bray GA.

Drug Insight: appetite suppressants. Bray GA. Nat Clin Pract Gastroenterol Hepatol. 2005 Feb;2(2):89-95. Review.

Drug treatment of obesity. Bray GA. Psychiatr Clin North Am. 2005 Mar;28(1):193-217, ix-x. Review. No abstract available.

The 20 most significant advances in obesity research, prevention and treatment. Foreword.
Bouchard C, Bray GA, Kozak L, Ravussin E. Int J Obes (Lond). 2008 Dec;32 Suppl 7:S1. No abstract available.

Medications for weight reduction. Bray GA. Endocrinol Metab Clin North Am. 2008 Dec;37(4):923-42.

Effects of diet and time of the day on serum and CSF leptin levels in Osborne-Mendel and S5B/Pl rats. Ishihara Y, White CL, Kageyama H, Kageyama A, York DA, Bray GA. Obes Res. 2004 Jul;12(7):1067-76.

Prediction equations for resting energy expenditure in overweight and normal-weight black and white children. McDuffie JR, Adler-Wailes DC, Elberg J, Steinberg EN, Fallon EM, Tershakovec AM, Arslanian SA, Delany JP, Bray GA, Yanovski JA. Am J Clin Nutr. 2004 Aug;80(2):365-73.

Effect of a beta-3 agonist on food intake in two strains of rats that differ in susceptibility to obesity. White CL, Ishihara Y, Dotson TL, Hughes DA, Bray GA, York DA. Physiol Behav. 2004 Sep;82(2-3):489-96.

A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial. Bray GA, Vollmer WM, Sacks FM, Obarzanek E, Svetkey LP, Appel LJ; DASH Collaborative Research Group. Am J Cardiol. 2004 Jul 15;94(2):222-7.

The epidemic of obesity and changes in food intake: the Fluoride Hypothesis. Bray GA. Physiol Behav. 2004 Aug;82(1):115-21.

The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo. Bogacka I, Xie H, Bray GA, Smith SR. Diabetes Care. 2004 Jul;27(7):1660-7.

Medical consequences of obesity. Bray GA. J Clin Endocrinol Metab. 2004 Jun;89(6):2583-9. Review.

Obesity and the Metabolic Syndrome: implications for dietetics practitioners. Bray GA, Champagne CM.. J Am Diet Assoc. 2004 Jan;104(1):86-9. Review.

Obesity is a chronic, relapsing neurochemical disease. Bray GA, Int J Obes Relat Metab Disord. 2004 Jan;28(1):34-8.

Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Allison DB, Downey M, Atkinson RL, Billington CJ, Bray GA, Eckel RH, Finkelstein EA, Jensen MD, Tremblay A. Obesity (Silver Spring). 2008 Jun;16(6):1161-77. Epub 2008 May 8. Review. No abstract available.

Pharmacological treatment of the overweight patient. Bray GA, Greenway FL. Pharmacol Rev. 2007 Jun;59(2):151-84. Review. No abstract available.

Overexpression of neuropeptide Y in the central nucleus of the amygdala decreases ethanol self-administration in "anxious" rats. Primeaux SD, Wilson SP, Bray GA, York DA, Wilson MA., Alcohol Clin Exp Res. 2006 May;30(5):791-801.

Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH., Arterioscler Thromb Vasc Biol. 2006 May;26(5):968-76. Review.

Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Bray GA, Bellanger T. Endocrine. 2006 Feb;29(1):109-17. Review.